ES2038722T3 - Procedimiento para preparar antagonistas de leucotrieno. - Google Patents

Procedimiento para preparar antagonistas de leucotrieno.

Info

Publication number
ES2038722T3
ES2038722T3 ES198888111747T ES88111747T ES2038722T3 ES 2038722 T3 ES2038722 T3 ES 2038722T3 ES 198888111747 T ES198888111747 T ES 198888111747T ES 88111747 T ES88111747 T ES 88111747T ES 2038722 T3 ES2038722 T3 ES 2038722T3
Authority
ES
Spain
Prior art keywords
preparing
procedure
antagonists
leucotrene
leucotrene antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888111747T
Other languages
English (en)
Inventor
Gunther Dr. Wess
Wilhelm Prof. Dr. Bartmann
Gerhard Dr. Beck
Hiristo Anagnostopulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2038722T3 publication Critical patent/ES2038722T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34Oxygen atoms
    • C07D317/36Alkylene carbonates; Substituted alkylene carbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

COMBINACIONES DE LA FORMULA(I) DONDE R1, R2, R3, R4, R5, R6 Y X TIENEN EL SIGNIFICADO DADO, METODO DE FABRICACION DE ESTAS COMBINACIONES, SU UTILIZACION COMO MEDICAMENTO Y PREPARACIONES FARMACEUTICAS SOBRE LA BASIS DE ESTAS COMBINACIONES ESTA DESCRITA.
ES198888111747T 1987-07-25 1988-07-21 Procedimiento para preparar antagonistas de leucotrieno. Expired - Lifetime ES2038722T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873724669 DE3724669A1 (de) 1987-07-25 1987-07-25 Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten

Publications (1)

Publication Number Publication Date
ES2038722T3 true ES2038722T3 (es) 1993-08-01

Family

ID=6332350

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888111747T Expired - Lifetime ES2038722T3 (es) 1987-07-25 1988-07-21 Procedimiento para preparar antagonistas de leucotrieno.

Country Status (16)

Country Link
US (1) US4855323A (es)
EP (1) EP0301402B1 (es)
JP (1) JPS6447729A (es)
KR (1) KR890001973A (es)
AT (1) ATE66468T1 (es)
AU (1) AU608868B2 (es)
DE (2) DE3724669A1 (es)
DK (1) DK412288A (es)
ES (1) ES2038722T3 (es)
FI (1) FI883454A (es)
GR (1) GR3002945T3 (es)
IL (1) IL87198A (es)
NO (1) NO167798C (es)
NZ (1) NZ225517A (es)
PT (1) PT88073B (es)
ZA (1) ZA885337B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9121656D0 (en) * 1991-10-11 1991-11-27 Ici Plc Chemical process
DE10355786A1 (de) * 2003-11-26 2005-06-30 Covion Organic Semiconductors Gmbh Konjugierte Polymere, deren Darstellung und Verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867434A (en) * 1971-11-04 1975-02-18 Rorer Inc William H Phenyl butyric acids and derivatives thereof
US3894080A (en) * 1970-05-05 1975-07-08 Rorer Inc William H Phenylacetic acids
AT336589B (de) * 1974-05-20 1977-05-10 Thomae Gmbh Dr K Verfahren zur herstellung von neuen biphenylderivaten
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
GB2190377A (en) * 1986-05-14 1987-11-18 Merck Frosst Canada Inc Phenyldithiaalkanedioic acids as leukotriene antagonists

Also Published As

Publication number Publication date
DK412288A (da) 1989-01-26
AU608868B2 (en) 1991-04-18
NZ225517A (en) 1990-11-27
NO167798B (no) 1991-09-02
KR890001973A (ko) 1989-04-07
AU1929588A (en) 1989-01-27
IL87198A (en) 1992-11-15
EP0301402A1 (de) 1989-02-01
NO167798C (no) 1991-12-11
DK412288D0 (da) 1988-07-22
IL87198A0 (en) 1988-12-30
ZA885337B (en) 1989-03-29
NO883285L (no) 1989-01-26
NO883285D0 (no) 1988-07-22
DE3724669A1 (de) 1989-02-02
PT88073B (pt) 1995-03-01
EP0301402B1 (de) 1991-08-21
FI883454A0 (fi) 1988-07-21
JPS6447729A (en) 1989-02-22
GR3002945T3 (en) 1993-01-25
DE3864345D1 (de) 1991-09-26
PT88073A (pt) 1989-06-30
ATE66468T1 (de) 1991-09-15
FI883454A (fi) 1989-01-26
US4855323A (en) 1989-08-08

Similar Documents

Publication Publication Date Title
ZA884919B (en) 3-demethylmevalonic acid derivatives,a process for their preparation,pharmaceutical products based on these compounds,their use and intermediates
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
ZA884922B (en) 3-demethyl-4-fluoromevalonic acid derivatives,a process for the preparation thereof,pharmaceutical products based on these compounds,the use thereof,and intermediates
PH19471A (en) Oxindole derivatives and pharmaceutical composition containing them
FI65616B (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara 1-oxadiazolylfenoxi-3-(4-fenylpiperazinyl)-propanol-2-derivat
HUT49876A (en) Process for producing 6-oxopyridazine derivatives and pharmaceutical compositions comprising same
ES2038722T3 (es) Procedimiento para preparar antagonistas de leucotrieno.
EP0301401A3 (en) Leukotriene antagonists, process for their preparation, their use in the treatment of illnesses, as well as precursors
ZA882854B (en) Substituted quinoxalyl-imidazolidine-2,4-diones,processes for their preparation,their use as medicaments and pharmaceutical preparations
GR3001809T3 (en) Benzylaminoaryldihydropyridine lactones, process for their preparation and their use in medicaments

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 301402

Country of ref document: ES